Hikma Pharmaceutical traded at 1,638.00 this Tuesday July 5th, decreasing 16.00 or 0.97 percent since the previous trading session. Looking back, over the last four weeks, Hikma Pharmaceutical lost 2.21 percent. Over the last 12 months, its price fell by 35.94 percent. Looking ahead, we forecast Hikma Pharmaceutical to be priced at 1,577.72 by the end of this quarter and at 1,453.34 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Almirall SA 10.87 0.08 0.74% -28.01%
argenx SE 368.10 6.80 1.88% 39.43%
Artemis Alpha 298.00 1.46 0.49% -33.18%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Bayer 55.52 -1.72 -3.00% 9.55%
Fresenius Medical Care 24.59 -0.52 -2.07% -38.69%
Fresenius 28.53 -0.79 -2.69% -34.89%
Genmab 2,407.00 54.00 2.29% -8.41%
Galapagos 54.90 1.84 3.47% -5.08%
GRIFOLS 17.56 -0.28 -1.54% -21.61%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Hikma Pharmaceutical 1,638.00 -16.00 -0.97% -35.94%
Lonza Group 529.60 4.80 0.91% -20.46%
Merck 167.85 2.45 1.48% 1.39%
Orion 43.72 0.97 2.27% 17.97%
Recordati 42.91 -0.11 -0.26% -14.35%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Sanofi 97.12 -1.22 -1.24% 11.93%
UCB 82.60 -0.04 -0.05% -6.92%

Indexes Price Day Year
GB100 7025 -207.18 -2.86% -1.06%

Hikma Pharmaceutical
Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products across the Middle East and North Africa (MENA) region and other markets. The Company sells specialized generic injectable products across the globe. It also sells non-injectable generic products in the United States, supplying over 300 products in different dosage strengths and forms. The Company's other businesses comprise Arab Medical Containers, a manufacturer of plastic specialized medicinal sterile containers, International Pharmaceuticals Research Centre, which conducts bio-equivalency studies, and the active pharmaceutical ingredient (API) manufacturing division of Hikma Pharmaceuticals Limited Jordan.